Bio-Rad Laboratories, Inc.
BIO.B- Exchange
- NYSE
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0000012208
No open-market purchases or sales by Bio-Rad Laboratories, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesBIO
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BIO.B, Q2 2026
No superinvestor reported holding BIO.B at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Bio-Rad Laboratories, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 13, 2026 (view filing) | May 11 | 2 days | Engelhardt Eva AnetteEVP, President, CDG | SSaleBio-Rad A Common Stock | −550 | $246.54 | −$135.6K | −61.4%346 after | |
| Nov 10, 2025 (view filing) | Nov 6 | 4 days | Barry JamesEVP, President, LSG | SSaleBio-Rad A Common Stock | −699.87 | $306.18 | −$214.3K | −57.9%509.68 after | |
| Mar 18, 2025 (view filing) | Mar 14 | 4 days | Crowley MichaelEVP, GBL Commercial Operations | SSaleBio-Rad A Common Stock | −3.00K | $247.06 | −$741.2K | −26.9%8.17K after | |
| Sep 10, 2024 (view filing) | Sep 6 | 4 days | Last Andrew J.EVP, Chief Operating Officer | SSaleBio-Rad A Common Stock | −3.00K | $329.94 | −$989.8K | −28.4%7.56K after | |
| Sep 4, 2024 (view filing) | Sep 4 | Same day | Barry JamesEVP, President, LSG | SSaleBio-Rad A Common Stock | −623 | $330.49 | −$205.9K | −81.0%146.56 after | |
| Jun 14, 2024 (view filing) | Jun 13 | 1 day | Crowley MichaelEVP, GBL Commercial Operations | SSaleBio-Rad A Common Stock | −369 | $281.91 | −$104.0K | −5.3%6.57K after | |
| May 1, 2024 (view filing) | May 3, 2023 | 364 daysLate | Schwartz Steven D10% Owner | SSaleBio-Rad A Common Stock | −320 | $463.86 | −$148.4K | −17.6%1.50K after | |
| Feb 29, 2024 (view filing) | Feb 28 | 1 day | Ernst Timothy SEVP, General Counsel & Sec | SSaleBio-Rad A Common Stock | −2.50K | $330.55 | −$826.4K | −42.4%3.40K after | |
| Feb 28, 2024 (view filing) | Feb 27 | 1 day | Crowley MichaelEVP, GBL Commercial Operations | SSaleBio-Rad A Common Stock | −3.00K | $336.00 | −$1.01M | −30.2%6.94K after | |
| Dec 12, 2023 (view filing) | Dec 12 | Same day | Wright DaraEVP, President, CDG | SSaleBio-Rad A Common Stock | −1.20K | $299.16 | −$359.0K | −44.5%1.50K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Bio-Rad Laboratories, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding BIO.B in 13F filings for Q2 2026.